Qiming Wang
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 2%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 79
- Lung Cancer Research Studies 42
- Cancer Immunotherapy and Biomarkers 14
- Peptidase Inhibition and Analysis 10
-
- Lung Cancer Treatments and Mutations 43
- Lung Cancer Diagnosis and Treatment 10
- Co-authors
- Sen Yang (11 shared papers)Zhe Zhang (1 shared paper)Yu Tang (1 shared paper)Wei Li (1 shared paper)Tao Yu (1 shared paper)Xi Wu (1 shared paper)Yongqian Shu (1 shared paper)Yuan Fang (1 shared paper)
- Journals
- Journal of Clinical Oncology (25 papers)Translational Lung Cancer Research (8 papers)Cancer Research (6 papers)Biochemical and Biophysical Research Communications (6 papers)Frontiers in Oncology (4 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Qiming Wang
179 papers receiving 4.3k citations
Qiming Wang's Hit Papers
Peers
Comparison fields: 5 of 124
- Cancer Research 733
- Oncology 1.2k
- Pulmonary and Respiratory Medicine 1.0k
- Molecular Biology 1.8k
- Immunology 411
Countries citing papers authored by Qiming Wang
This map shows the geographic impact of Qiming Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiming Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiming Wang more than expected).
Fields of papers citing papers by Qiming Wang
This network shows the impact of papers produced by Qiming Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiming Wang. The network helps show where Qiming Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Qiming Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 192 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pyroptosis: A new frontier in cancer Hit paper breakdown → | 2019 | 810 |
| 2 | Emerging therapies for small cell lung cancer Hit paper breakdown → | 2019 | 311 |
| 3 | MEK inhibitors for the treatment of non-small cell lung cancer Hit paper breakdown → | 2021 | 231 |
| 4 | 2019 | 200 | |
| 5 | 2020 | 142 | |
| 6 | 2011 | 135 | |
| 7 | 2011 | 117 | |
| 8 | 2021 | 108 | |
| 9 | Roles of exosomes in immunotherapy for solid cancers Hit paper breakdown → | 2024 | 79 |
| 10 | 2023 | 72 | |
| 11 | 2020 | 58 | |
| 12 | 2021 | 54 | |
| 13 | 2019 | 53 | |
| 14 | 2012 | 49 | |
| 15 | 2012 | 44 | |
| 16 | 2010 | 44 | |
| 17 | 2017 | 42 | |
| 18 | 2022 | 42 | |
| 19 | 2021 | 38 | |
| 20 | 2009 | 38 |
About Qiming Wang
Qiming Wang is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research and Surgery, having authored 192 papers that have together received 4.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (43 papers), Lung Cancer Research Studies (42 papers), Cancer-related molecular mechanisms research (14 papers), Cancer Immunotherapy and Biomarkers (14 papers), Cancer Genomics and Diagnostics (12 papers), Lung Cancer Diagnosis and Treatment (10 papers), Peptidase Inhibition and Analysis (10 papers) and Cancer-related gene regulation (7 papers). The work is most often cited by research in Cancer Research (733 citations), Oncology (1.2k citations), Pulmonary and Respiratory Medicine (1.0k citations), Molecular Biology (1.8k citations) and Immunology (411 citations). Qiming Wang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Sen Yang, Zhe Zhang, Yu Tang, Wei Li, Tao Yu, Xi Wu, Yongqian Shu, Yuan Fang, Pei Ma and Yutian Pan. Their work appears in journals such as Journal of Clinical Oncology, Translational Lung Cancer Research, Cancer Research, Biochemical and Biophysical Research Communications and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.